Literature DB >> 27287660

A multi-analyte panel for non-invasive pharmacokinetic monitoring of second-line anti-tuberculosis drugs.

Roy Gerona1, Anita Wen1, Catherine Koss2, Peter Bacchetti3, Monica Gandhi2, John Metcalfe4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27287660      PMCID： PMC5119745          DOI： 10.5588/ijtld.16.0201

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  5 in total

1.  Simultaneous determination of first-line anti-tuberculosis drugs and their major metabolic ratios by liquid chromatography/tandem mass spectrometry.

Authors:  Sang Hoon Song; Sun Hee Jun; Kyoung Un Park; Yeomin Yoon; Jae Ho Lee; Jin Q Kim; Junghan Song
Journal:  Rapid Commun Mass Spectrom       Date:  2007       Impact factor: 2.419

2.  Method for simultaneous analysis of nine second-line anti-tuberculosis drugs using UPLC-MS/MS.

Authors:  Minje Han; Sun Hee Jun; Jae Ho Lee; Kyoung Un Park; Junghan Song; Sang Hoon Song
Journal:  J Antimicrob Chemother       Date:  2013-05-08       Impact factor: 5.790

3.  Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry.

Authors:  Hyo-Ji Kim; Kyung-Ah Seo; Hyun-Mi Kim; Eun-Sook Jeong; Jong Lyul Ghim; Seung Heon Lee; Young Min Lee; Dong Hyun Kim; Jae-Gook Shin
Journal:  J Pharm Biomed Anal       Date:  2014-09-01       Impact factor: 3.935

Review 4.  New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects.

Authors:  Alimuddin I Zumla; Stephen H Gillespie; Michael Hoelscher; Patrick P J Philips; Stewart T Cole; Ibrahim Abubakar; Timothy D McHugh; Marco Schito; Markus Maeurer; Andrew J Nunn
Journal:  Lancet Infect Dis       Date:  2014-04       Impact factor: 25.071

5.  Moving Beyond Directly Observed Therapy for Tuberculosis.

Authors:  John Z Metcalfe; Max R O'Donnell; David R Bangsberg
Journal:  PLoS Med       Date:  2015-09-15       Impact factor: 11.069
  5 in total
  4 in total

1.  Simultaneous analysis of 11 medications for drug resistant TB in small hair samples to quantify adherence and exposure using a validated LC-MS/MS panel.

Authors:  Roy Gerona; Anita Wen; David Aguilar; Jamie Shum; Andrew Reckers; Peter Bacchetti; Monica Gandhi; John Metcalfe
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2019-07-23       Impact factor: 3.205

2.  Correlation of Linezolid Hair Concentrations with Plasma Exposure in Patients with Drug-Resistant Tuberculosis.

Authors:  Sean Wasserman; Shu Huo; Karina Ky; Ysabella Noelle Malig; Ali Esmail; Keertan Dheda; Peter Bacchetti; Roy Gerona; Gary Maartens; Monica Gandhi; John Metcalfe
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

3.  Development and validation of a liquid chromatography-tandem mass spectrometry method for quantifying delamanid and its metabolite in small hair samples.

Authors:  Andrew Reckers; Stella Huo; Ali Esmail; Keertan Dheda; Peter Bacchetti; Monica Gandhi; John Metcalfe; Roy Gerona
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2020-12-10       Impact factor: 3.205

4.  Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB.

Authors:  John Metcalfe; Peter Bacchetti; Roy Gerona; Ali Esmail; Keertan Dheda; Monica Gandhi
Journal:  ERJ Open Res       Date:  2019-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.